The Cancer Letter

Inside information on cancer research and drug development

Vol.
36
No.
31
September 03, 2010Sep 03, 2010
DOWNLOAD THE PDF

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

Login

Looking for IP Login?